139 related articles for article (PubMed ID: 3617098)
21. Formation of DHP-derived DNA adducts from metabolic activation of the prototype heliotridine-type pyrrolizidine alkaloid, heliotrine.
Xia Q; Yan J; Chou MW; Fu PP
Toxicol Lett; 2008 May; 178(2):77-82. PubMed ID: 18395999
[TBL] [Abstract][Full Text] [Related]
22. Induction of rabbit hepatic microsomal cytochrome P-450 by imidazole: enhanced metabolic activity and altered substrate specificity.
Kaul KL; Novak RF
Arch Biochem Biophys; 1984 Dec; 235(2):470-81. PubMed ID: 6517600
[TBL] [Abstract][Full Text] [Related]
23. Two dihydropyrrolizine alkaloid metabolites isolated from mouse hepatic microsomes in vitro.
Segall HJ; Dallas JL; Haddon WF
Drug Metab Dispos; 1984; 12(1):68-71. PubMed ID: 6141915
[TBL] [Abstract][Full Text] [Related]
24. Loss of rat liver microsomal cytochrome P-450 during methimazole metabolism. Role of flavin-containing monooxygenase.
Kedderis GL; Rickert DE
Drug Metab Dispos; 1985; 13(1):58-61. PubMed ID: 2858378
[TBL] [Abstract][Full Text] [Related]
25. Configuration of necine pyrroles--toxic metabolites of pyrrolizidine alkaloids.
Kedzierski B; Buhler DR
Toxicol Lett; 1985 May; 25(2):115-9. PubMed ID: 4002242
[TBL] [Abstract][Full Text] [Related]
26. The formation of 6,7-dihydro-7-hydroxy-1-hydroxy-methyl-5H-pyrrolizine, a metabolite of pyrrolizidine alkaloids.
Kedzierski B; Buhler DR
Chem Biol Interact; 1986 Feb; 57(2):217-22. PubMed ID: 3955792
[TBL] [Abstract][Full Text] [Related]
27. Pyridine nucleotide cofactor requirements of indicine N-oxide reduction by hepatic microsomal cytochrome P-450.
Powis G; Wincentsen L
Biochem Pharmacol; 1980 Feb; 29(3):347-51. PubMed ID: 6767485
[No Abstract] [Full Text] [Related]
28. trans-4-Hydroxy-2-hexenal: a reactive metabolite from the macrocyclic pyrrolizidine alkaloid senecionine.
Segall HJ; Wilson DW; Dallas JL; Haddon WF
Science; 1985 Aug; 229(4712):472-5. PubMed ID: 4012327
[TBL] [Abstract][Full Text] [Related]
29. Determination of pyrrolizidine alkaloid metabolites from mouse liver microsomes using tandem mass spectrometry and gas chromatography/mass spectrometry.
Winter CK; Segall HJ; Jones AD
Biomed Environ Mass Spectrom; 1988 Mar; 15(5):265-73. PubMed ID: 3365497
[TBL] [Abstract][Full Text] [Related]
30. Pyrrolic and N-oxide metabolites formed from pyrrolizidine alkaloids by hepatic microsomes in vitro: relevance to in vivo hepatotoxicity.
Mattocks AR; Bird I
Chem Biol Interact; 1983 Feb; 43(2):209-22. PubMed ID: 6825198
[TBL] [Abstract][Full Text] [Related]
31. Further evidence on the intramolecular lactonization in rat liver microsomal metabolism of 12-O-acetylated retronecine-type pyrrolizidine alkaloids.
Tang J; Wang Z; Akao T; Hattori M
Nat Prod Commun; 2013 Nov; 8(11):1545-6. PubMed ID: 24427937
[TBL] [Abstract][Full Text] [Related]
32. Dietary selenium status and pyrrolizidine alkaloid metabolism in vitro by rat liver microsomes.
Shull LR; Buckmaster GW; Cheeke PR
Res Commun Chem Pathol Pharmacol; 1977 Jun; 17(2):337-40. PubMed ID: 877417
[TBL] [Abstract][Full Text] [Related]
33. In vitro metabolism of isoline, a pyrrolizidine alkaloid from Ligularia duciformis, by rodent liver microsomal esterase and enhanced hepatotoxicity by esterase inhibitors.
Tang J; Akao T; Nakamura N; Wang ZT; Takagawa K; Sasahara M; Hattori M
Drug Metab Dispos; 2007 Oct; 35(10):1832-9. PubMed ID: 17639025
[TBL] [Abstract][Full Text] [Related]
34. Characterization of the oxidation of amine metabolites of nitrotoluenes by rat hepatic microsomes. N- and C-hydroxylation.
Kedderis GL; Rickert DE
Mol Pharmacol; 1985 Aug; 28(2):207-14. PubMed ID: 4022002
[TBL] [Abstract][Full Text] [Related]
35. Metabolic activation of retronecine and retronecine N-oxide - formation of DHP-derived DNA adducts.
Yan J; Xia Q; Chou MW; Fu PP
Toxicol Ind Health; 2008 Apr; 24(3):181-8. PubMed ID: 18842697
[TBL] [Abstract][Full Text] [Related]
36. Iron-EDTA stimulated reduction of indicine N-oxide by the hepatic microsomal fraction, isolated hepatocytes, and the intact rat.
Powis G; Svingen BA; Degraw C
Biochem Pharmacol; 1982 Feb; 31(3):293-9. PubMed ID: 6280724
[TBL] [Abstract][Full Text] [Related]
37. The conversion of the pyrrolizidine alkaloid retrorsine to pyrrolic derivatives in vivo and in vitro and its acute toxicity to various animal species.
White IN; Mattocks AR; Butler WH
Chem Biol Interact; 1973 Apr; 6(4):207-18. PubMed ID: 4704120
[No Abstract] [Full Text] [Related]
38. Specific recognition, detoxification and metabolism of pyrrolizidine alkaloids by the polyphagous arctiid Estigmene acrea.
Hartmann T; Theuring C; Beuerle T; Klewer N; Schulz S; Singer MS; Bernays EA
Insect Biochem Mol Biol; 2005 May; 35(5):391-411. PubMed ID: 15804574
[TBL] [Abstract][Full Text] [Related]
39. Microsomal metabolism of the carcinogen, N-2-fluorenylacetamide, by the mammary gland and liver of female rats. I. Ring- and N-hydroxylations of N-2-fluorenylacetamide.
Malejka-Giganti D; Decker RW; Ritter CL; Polovina MR
Carcinogenesis; 1985 Jan; 6(1):95-103. PubMed ID: 3967341
[TBL] [Abstract][Full Text] [Related]
40. Microsomal flavin-containing monooxygenase activity in rat corpus striatum.
Duffel MW; Gillespie SG
J Neurochem; 1984 May; 42(5):1350-3. PubMed ID: 6707640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
